Literature DB >> 1380732

In vivo biology and therapeutic potential of hematopoietic growth factors and circulating progenitor cells.

F Herrmann1, W Brugger, L Kanz, R Mertelsmann.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1380732

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  3 in total

1.  Marker gene transfer into leukapheresis preparations containing hematopoietic progenitor cells: application in high-dose therapy rescued by reinfusion of peripheral blood hematopoietic progenitors in patients with multiple myeloma.

Authors:  F Herrmann; M Kiehntopf; M A Brach; D Carstanjen; C von Schilling
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

2.  Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

Authors:  J W Thomas; C M Baum; W F Hood; B Klein; J B Monahan; K Paik; N Staten; M Abrams; J P McKearn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

3.  Carboplatin-liposomes (CPL) in immunodeficient mice: improved antitumor activity for breast carcinomas and stimulation of hematopoiesis.

Authors:  I Fichtner; R Reszka; S R Goan; H Naundorf
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.